JP6782700B2 - 膵・消化管神経内分泌新生物の診断のための組成物、方法およびキット - Google Patents

膵・消化管神経内分泌新生物の診断のための組成物、方法およびキット Download PDF

Info

Publication number
JP6782700B2
JP6782700B2 JP2017533744A JP2017533744A JP6782700B2 JP 6782700 B2 JP6782700 B2 JP 6782700B2 JP 2017533744 A JP2017533744 A JP 2017533744A JP 2017533744 A JP2017533744 A JP 2017533744A JP 6782700 B2 JP6782700 B2 JP 6782700B2
Authority
JP
Japan
Prior art keywords
nen
gep
expression
biomarkers
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017533744A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017528164A5 (enExample
JP2017528164A (ja
Inventor
アーヴィン マーク モドリン
アーヴィン マーク モドリン
マーク キッド
マーク キッド
イグナット ドロズドフ
イグナット ドロズドフ
Original Assignee
クリフトン ライフ サイエンシズ リミテッド ライアビリティ カンパニー
クリフトン ライフ サイエンシズ リミテッド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by クリフトン ライフ サイエンシズ リミテッド ライアビリティ カンパニー, クリフトン ライフ サイエンシズ リミテッド ライアビリティ カンパニー filed Critical クリフトン ライフ サイエンシズ リミテッド ライアビリティ カンパニー
Publication of JP2017528164A publication Critical patent/JP2017528164A/ja
Publication of JP2017528164A5 publication Critical patent/JP2017528164A5/ja
Application granted granted Critical
Publication of JP6782700B2 publication Critical patent/JP6782700B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2017533744A 2014-09-15 2015-09-15 膵・消化管神経内分泌新生物の診断のための組成物、方法およびキット Active JP6782700B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462050465P 2014-09-15 2014-09-15
US62/050,465 2014-09-15
PCT/US2015/050274 WO2016044330A1 (en) 2014-09-15 2015-09-15 Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020175701A Division JP7157788B2 (ja) 2014-09-15 2020-10-20 膵・消化管神経内分泌新生物の診断のための組成物、方法およびキット

Publications (3)

Publication Number Publication Date
JP2017528164A JP2017528164A (ja) 2017-09-28
JP2017528164A5 JP2017528164A5 (enExample) 2018-10-18
JP6782700B2 true JP6782700B2 (ja) 2020-11-11

Family

ID=54207775

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017533744A Active JP6782700B2 (ja) 2014-09-15 2015-09-15 膵・消化管神経内分泌新生物の診断のための組成物、方法およびキット
JP2020175701A Active JP7157788B2 (ja) 2014-09-15 2020-10-20 膵・消化管神経内分泌新生物の診断のための組成物、方法およびキット

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020175701A Active JP7157788B2 (ja) 2014-09-15 2020-10-20 膵・消化管神経内分泌新生物の診断のための組成物、方法およびキット

Country Status (13)

Country Link
US (3) US10407730B2 (enExample)
EP (2) EP3194618B1 (enExample)
JP (2) JP6782700B2 (enExample)
KR (2) KR20250021631A (enExample)
CN (1) CN107208132A (enExample)
AU (3) AU2015317893B2 (enExample)
CA (1) CA2959670C (enExample)
DK (2) DK3194618T3 (enExample)
ES (2) ES3013599T3 (enExample)
IL (2) IL250867B (enExample)
MX (2) MX386919B (enExample)
PL (2) PL3929303T3 (enExample)
WO (1) WO2016044330A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015317893B2 (en) 2014-09-15 2021-05-20 Clifton Life Sciences LLC Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
BR112019024481A2 (pt) * 2017-05-25 2020-07-14 Liquid Biopsy Research LLC métodos para detecção de melanoma
IL317236A (en) * 2017-11-30 2025-01-01 Liquid Biopsy Res Llc Predicting peptide receptor radiotherapy using gene expression testing
CN108048564B (zh) * 2018-02-09 2021-03-05 中国科学院昆明动物研究所 人glt8d1基因的新用途
SG11202100047YA (en) * 2018-07-30 2021-02-25 Agency Science Tech & Res Method and system for assessing fibrosis in a tissue sample
US20210108259A1 (en) 2019-10-10 2021-04-15 Liquid Biopsy Research LLC Compositions, methods and kits for biological sample and rna stabilization
FR3110764B1 (fr) 2020-05-20 2024-05-10 Quantum Surgical Méthode de prédiction de la récidive d’une lésion par analyse d’images
CN113215255B (zh) * 2021-04-26 2022-04-05 山东天川精准医疗科技有限公司 用于肝癌早期诊断或预后的生物标记物及其用途
WO2024015968A2 (en) * 2022-07-15 2024-01-18 Emendobio Inc. Strategies for knock-ins at aplp2 safe harbor sites
JP2025532965A (ja) * 2022-09-30 2025-10-03 リキッド バイオプシー リサーチ リミティド ライアビリティ カンパニー 唾液での神経内分泌がん検出方法
CN117292755A (zh) * 2023-08-09 2023-12-26 郑州大学 多模态临界边生物标志物识别方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050084883A1 (en) * 2003-08-25 2005-04-21 The Johns Hopkins University School Of Medicine Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differential gene expression analysis
EP3590956A1 (en) 2008-06-12 2020-01-08 Ipsen Bioinnovation Limited Suppression of neuroendocrine diseases
ES2656487T3 (es) * 2011-03-01 2018-02-27 Yale University Evaluación de la respuesta a la terapia de neoplasmas neuroendocrinos gastroenteropancreáticas (GEP-NEN)
AU2015317893B2 (en) 2014-09-15 2021-05-20 Clifton Life Sciences LLC Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Also Published As

Publication number Publication date
BR112017005279A2 (pt) 2017-12-12
CA2959670A1 (en) 2016-03-24
DK3929303T3 (da) 2025-03-03
KR20250021631A (ko) 2025-02-13
ES2881474T3 (es) 2021-11-29
AU2015317893B2 (en) 2021-05-20
JP7157788B2 (ja) 2022-10-20
US20190345568A1 (en) 2019-11-14
WO2016044330A1 (en) 2016-03-24
MX386919B (es) 2025-03-19
DK3194618T3 (da) 2021-07-12
US20160076106A1 (en) 2016-03-17
CN107208132A (zh) 2017-09-26
ES3013599T3 (en) 2025-04-14
AU2021212151A1 (en) 2021-08-26
EP3194618A1 (en) 2017-07-26
MX2021012347A (es) 2021-10-22
PL3194618T3 (pl) 2021-12-13
IL250867A0 (en) 2017-04-30
US20220325351A1 (en) 2022-10-13
EP3929303A1 (en) 2021-12-29
IL281355A (en) 2021-04-29
PL3929303T3 (pl) 2025-04-28
EP3194618B1 (en) 2021-04-21
US12258633B2 (en) 2025-03-25
AU2023258444A1 (en) 2023-11-23
US10407730B2 (en) 2019-09-10
MX2017003370A (es) 2017-11-22
KR20170045365A (ko) 2017-04-26
JP2017528164A (ja) 2017-09-28
EP3929303B1 (en) 2024-12-04
KR102762958B1 (ko) 2025-02-04
AU2021212151B2 (en) 2023-08-03
JP2021019618A (ja) 2021-02-18
AU2015317893A1 (en) 2017-03-23
CA2959670C (en) 2024-02-20
US11168372B2 (en) 2021-11-09
IL250867B (en) 2021-03-25
IL281355B (en) 2022-02-01

Similar Documents

Publication Publication Date Title
JP7157788B2 (ja) 膵・消化管神経内分泌新生物の診断のための組成物、方法およびキット
AU2017204086B2 (en) Predicting gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)
HK40066027B (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
HK40066027A (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
HK1241416B (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
BR112017005279B1 (pt) Métodos para detectar um neoplasma neuroendócrino gastroenteropancreático (gep-nen), para diferenciar gep-nen estável de um gep-nen progressivo e para determinar uma resposta a uma terapia com radionucleotídeo para receptor de peptídeo de um gep-nen
HK1193127A (en) Evaluating response to therapy of gastroenteropancreatic neuroendocrine neoplasms (gep-nens)
HK1193127B (en) Evaluating response to therapy of gastroenteropancreatic neuroendocrine neoplasms (gep-nens)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170531

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170410

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180910

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180910

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190808

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200311

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200326

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200824

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200911

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201020

R150 Certificate of patent or registration of utility model

Ref document number: 6782700

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250